We are live on
!
Find out more
EPL
EDBI Pte Ltd Portfolio holdings
AUM
$94.4M
1-Year Est. Return
32.71%
This Fund
S&P 500
This Quarter
Est. Return
-22.38%
1 Year Est. Return
+32.71%
3 Year Est. Return
+6.21%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$210M
Cap. Flow
% of AUM
114.02%
Top 10 Holdings %
Top 10 Hldgs %
95.15%
Holding
19
New
19
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Joby Aviation
JOBY
|
+$51.8M |
| 2 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
+$22M |
| 3 |
Grab
GRAB
|
+$21.5M |
| 4 |
Sprinklr
CXM
|
+$18.2M |
| 5 |
Snowflake
SNOW
|
+$17.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.59% |
| 2 | Healthcare | 31.14% |
| 3 | Industrials | 28.28% |
| 4 | Miscellaneous | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Joby Aviation
JOBY
$7.07B
| $45.5M | 24.72% |
+6,231,565
| New | +$51.8M |
|
|
2
Grab
GRAB
$14.7B
| $20.1M | 10.93% |
+2,822,035
| New | +$21.5M |
|
|
FMTX
3
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $18M | 9.8% |
+1,268,805
| New | +$22M |
|
|
4
Sprinklr
CXM
$1.86B
| $17.6M | 9.58% |
+1,110,777
| New | +$18.2M |
|
|
5
Snowflake
SNOW
$114B
| $17.2M | 9.32% |
+50,652
| New | +$17.7M |
|
|
WKME
6
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $15M | 8.13% |
+761,864
| New | +$17.1M |
|
7
Erasca
ERAS
$6.82B
| $13.8M | 7.52% |
+888,888
| New | +$15.2M |
|
8
Nuvation Bio
NUVB
$2.45B
| $10.8M | 5.87% |
+1,270,504
| New | +$11.7M |
|
|
NBP
9
NovaBridge Biosciences American Depositary Shares
NBP
$219M
| $10.5M | 5.72% |
+222,136
| New | +$13.3M |
|
10
Planet Labs
PL
$7.54B
| $6.55M | 3.56% |
+1,065,593
| New | +$10.1M |
|
11
AvePoint
AVPT
$3.03B
| $4.4M | 2.39% |
+700,000
| New | +$5.42M |
|
|
PEAR
12
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
| $2.64M | 1.44% |
+426,371
| New | +$3.81M |
|
13
Keros Therapeutics
KROS
$223M
| $591K | 0.32% |
+10,105
| New | +$504K |
|
14
Datadog
DDOG
$87.2B
| $437K | 0.24% |
+2,454
| New | +$417K |
|
15
Rapid Micro Biosystems
RPID
$80.8M
| $261K | 0.14% |
+24,515
| New | +$383K |
|
16
Relay Therapeutics
RLAY
$4.26B
| $230K | 0.13% |
+7,484
| New | +$237K |
|
17
Nurix Therapeutics
NRIX
$2.79B
| $215K | 0.12% |
+7,442
| New | +$226K |
|
18
ALX Oncology
ALXO
$283M
| $121K | 0.07% |
+5,613
| New | +$242K |
|
19
Olema Pharmaceuticals
OLMA
$944M
| $30K | 0.02% |
+3,181
| New | +$65.9K |
|
Similar funds
TB
GIM
MFIMFI
ACM
SW
RCM
TKP
WWS
EDBI Pte Ltd's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for EDBI Pte Ltd, which disclosed 19 positions worth $184M. Its ten largest holdings account for 95% of the portfolio.
Its largest position is Joby Aviation: 6,231,565 shares worth $45.5M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, followed by Healthcare and Industrials.
- EDBI Pte Ltd's largest Q4 2021 buy was Joby Aviation: 6,231,565 shares worth $45.5M.
- EDBI Pte Ltd's ten largest holdings make up 95% of its $184M portfolio in Q4 2021.
- EDBI Pte Ltd disclosed 19 positions in Q4 2021, its first 13F filing on record.
Based on EDBI Pte Ltd's 13F filing for Q4 2021, filed 25 Feb 2022.